nodes	percent_of_prediction	percent_of_DWPC	metapath
Cevimeline—FMO1—Cimetidine—obesity	0.475	0.717	CbGbCtD
Cevimeline—CYP2D6—Phentermine—obesity	0.0293	0.0443	CbGbCtD
Cevimeline—CYP2D6—Bupropion—obesity	0.025	0.0376	CbGbCtD
Cevimeline—CYP3A4—Sibutramine—obesity	0.0246	0.0371	CbGbCtD
Cevimeline—CYP2D6—Methamphetamine—obesity	0.0235	0.0354	CbGbCtD
Cevimeline—CYP3A4—Benzphetamine—obesity	0.0187	0.0281	CbGbCtD
Cevimeline—CYP2D6—Cimetidine—obesity	0.0183	0.0276	CbGbCtD
Cevimeline—CYP3A4—Bupropion—obesity	0.0159	0.0239	CbGbCtD
Cevimeline—CYP3A4—Orlistat—obesity	0.0129	0.0195	CbGbCtD
Cevimeline—CYP3A4—Cimetidine—obesity	0.0116	0.0176	CbGbCtD
Cevimeline—CYP3A4—Topiramate—obesity	0.00762	0.0115	CbGbCtD
Cevimeline—CHRM3—muscle of abdomen—obesity	0.00562	0.323	CbGeAlD
Cevimeline—FMO1—pituitary gland—obesity	0.00132	0.076	CbGeAlD
Cevimeline—FMO1—adipose tissue—obesity	0.00131	0.0757	CbGeAlD
Cevimeline—FMO1—digestive system—obesity	0.00124	0.0713	CbGeAlD
Cevimeline—FMO1—adrenal gland—obesity	0.00118	0.0679	CbGeAlD
Cevimeline—FMO1—endocrine gland—obesity	0.00102	0.0589	CbGeAlD
Cevimeline—FMO1—liver—obesity	0.000922	0.0531	CbGeAlD
Cevimeline—CYP2D6—hindbrain—obesity	0.000708	0.0408	CbGeAlD
Cevimeline—CHRM1—cardiovascular system—obesity	0.000685	0.0394	CbGeAlD
Cevimeline—CHRM3—adipose tissue—obesity	0.00054	0.0311	CbGeAlD
Cevimeline—CHRM3—digestive system—obesity	0.000509	0.0293	CbGeAlD
Cevimeline—CHRM1—endocrine gland—obesity	0.00047	0.027	CbGeAlD
Cevimeline—CHRM3—endocrine gland—obesity	0.00042	0.0242	CbGeAlD
Cevimeline—CYP3A4—digestive system—obesity	0.000279	0.0161	CbGeAlD
Cevimeline—CYP2D6—digestive system—obesity	0.000275	0.0158	CbGeAlD
Cevimeline—CYP3A4—endocrine gland—obesity	0.000231	0.0133	CbGeAlD
Cevimeline—CYP2D6—endocrine gland—obesity	0.000227	0.0131	CbGeAlD
Cevimeline—CYP3A4—liver—obesity	0.000208	0.012	CbGeAlD
Cevimeline—CYP2D6—liver—obesity	0.000205	0.0118	CbGeAlD
Cevimeline—Chills—Bupropion—obesity	0.000117	0.00051	CcSEcCtD
Cevimeline—Vertigo—Sibutramine—obesity	0.000117	0.000509	CcSEcCtD
Cevimeline—Syncope—Sibutramine—obesity	0.000116	0.000509	CcSEcCtD
Cevimeline—Convulsion—Orlistat—obesity	0.000116	0.000508	CcSEcCtD
Cevimeline—Leukopenia—Sibutramine—obesity	0.000116	0.000508	CcSEcCtD
Cevimeline—Arrhythmia—Bupropion—obesity	0.000116	0.000507	CcSEcCtD
Cevimeline—Face oedema—Topiramate—obesity	0.000116	0.000505	CcSEcCtD
Cevimeline—Alopecia—Bupropion—obesity	0.000115	0.000502	CcSEcCtD
Cevimeline—Palpitations—Sibutramine—obesity	0.000115	0.000501	CcSEcCtD
Cevimeline—Myalgia—Orlistat—obesity	0.000114	0.000499	CcSEcCtD
Cevimeline—Chest pain—Orlistat—obesity	0.000114	0.000499	CcSEcCtD
Cevimeline—Loss of consciousness—Sibutramine—obesity	0.000114	0.000498	CcSEcCtD
Cevimeline—Urinary retention—Topiramate—obesity	0.000114	0.000497	CcSEcCtD
Cevimeline—Anxiety—Orlistat—obesity	0.000114	0.000497	CcSEcCtD
Cevimeline—Mood swings—Topiramate—obesity	0.000113	0.000495	CcSEcCtD
Cevimeline—Cough—Sibutramine—obesity	0.000113	0.000495	CcSEcCtD
Cevimeline—Malnutrition—Bupropion—obesity	0.000113	0.000494	CcSEcCtD
Cevimeline—Discomfort—Orlistat—obesity	0.000113	0.000493	CcSEcCtD
Cevimeline—Convulsion—Sibutramine—obesity	0.000112	0.000491	CcSEcCtD
Cevimeline—Hypertension—Sibutramine—obesity	0.000112	0.00049	CcSEcCtD
Cevimeline—Flatulence—Bupropion—obesity	0.000111	0.000487	CcSEcCtD
Cevimeline—Dehydration—Topiramate—obesity	0.000111	0.000486	CcSEcCtD
Cevimeline—Dysgeusia—Bupropion—obesity	0.000111	0.000484	CcSEcCtD
Cevimeline—Myalgia—Sibutramine—obesity	0.00011	0.000483	CcSEcCtD
Cevimeline—Arthralgia—Sibutramine—obesity	0.00011	0.000483	CcSEcCtD
Cevimeline—Chest pain—Sibutramine—obesity	0.00011	0.000483	CcSEcCtD
Cevimeline—Anxiety—Sibutramine—obesity	0.00011	0.000481	CcSEcCtD
Cevimeline—Oedema—Orlistat—obesity	0.000109	0.000478	CcSEcCtD
Cevimeline—Back pain—Bupropion—obesity	0.000109	0.000478	CcSEcCtD
Cevimeline—Orthostatic hypotension—Topiramate—obesity	0.000109	0.000478	CcSEcCtD
Cevimeline—Discomfort—Sibutramine—obesity	0.000109	0.000477	CcSEcCtD
Cevimeline—Hypokalaemia—Topiramate—obesity	0.000109	0.000476	CcSEcCtD
Cevimeline—Muscle spasms—Bupropion—obesity	0.000109	0.000475	CcSEcCtD
Cevimeline—Infection—Orlistat—obesity	0.000109	0.000475	CcSEcCtD
Cevimeline—Nervous system disorder—Orlistat—obesity	0.000107	0.000469	CcSEcCtD
Cevimeline—Confusional state—Sibutramine—obesity	0.000107	0.000467	CcSEcCtD
Cevimeline—Skin disorder—Orlistat—obesity	0.000106	0.000465	CcSEcCtD
Cevimeline—Tremor—Bupropion—obesity	0.000106	0.000463	CcSEcCtD
Cevimeline—Gastritis—Topiramate—obesity	0.000106	0.000463	CcSEcCtD
Cevimeline—Oedema—Sibutramine—obesity	0.000106	0.000463	CcSEcCtD
Cevimeline—Hyperhidrosis—Orlistat—obesity	0.000106	0.000462	CcSEcCtD
Cevimeline—Muscular weakness—Topiramate—obesity	0.000106	0.000461	CcSEcCtD
Cevimeline—Alanine aminotransferase increased—Topiramate—obesity	0.000106	0.000461	CcSEcCtD
Cevimeline—Infection—Sibutramine—obesity	0.000105	0.00046	CcSEcCtD
Cevimeline—Ill-defined disorder—Bupropion—obesity	0.000105	0.000459	CcSEcCtD
Cevimeline—Anaemia—Bupropion—obesity	0.000105	0.000457	CcSEcCtD
Cevimeline—Shock—Sibutramine—obesity	0.000104	0.000455	CcSEcCtD
Cevimeline—Abdominal distension—Topiramate—obesity	0.000104	0.000455	CcSEcCtD
Cevimeline—Agitation—Bupropion—obesity	0.000104	0.000454	CcSEcCtD
Cevimeline—Thrombocytopenia—Sibutramine—obesity	0.000104	0.000453	CcSEcCtD
Cevimeline—Dysphagia—Topiramate—obesity	0.000103	0.000452	CcSEcCtD
Cevimeline—Asthma—Topiramate—obesity	0.000103	0.000452	CcSEcCtD
Cevimeline—Tachycardia—Sibutramine—obesity	0.000103	0.000452	CcSEcCtD
Cevimeline—Skin disorder—Sibutramine—obesity	0.000103	0.00045	CcSEcCtD
Cevimeline—Eosinophilia—Topiramate—obesity	0.000102	0.000448	CcSEcCtD
Cevimeline—Hyperhidrosis—Sibutramine—obesity	0.000102	0.000447	CcSEcCtD
Cevimeline—Malaise—Bupropion—obesity	0.000102	0.000446	CcSEcCtD
Cevimeline—Vertigo—Bupropion—obesity	0.000102	0.000444	CcSEcCtD
Cevimeline—Syncope—Bupropion—obesity	0.000101	0.000443	CcSEcCtD
Cevimeline—Leukopenia—Bupropion—obesity	0.000101	0.000443	CcSEcCtD
Cevimeline—Anorexia—Sibutramine—obesity	0.000101	0.000441	CcSEcCtD
Cevimeline—Angina pectoris—Topiramate—obesity	0.000101	0.00044	CcSEcCtD
Cevimeline—Sweating increased—Topiramate—obesity	0.000101	0.00044	CcSEcCtD
Cevimeline—Palpitations—Bupropion—obesity	9.99e-05	0.000437	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Orlistat—obesity	9.97e-05	0.000436	CcSEcCtD
Cevimeline—Bronchitis—Topiramate—obesity	9.95e-05	0.000435	CcSEcCtD
Cevimeline—Loss of consciousness—Bupropion—obesity	9.94e-05	0.000435	CcSEcCtD
Cevimeline—Insomnia—Orlistat—obesity	9.9e-05	0.000433	CcSEcCtD
Cevimeline—Hypotension—Sibutramine—obesity	9.89e-05	0.000432	CcSEcCtD
Cevimeline—Cough—Bupropion—obesity	9.87e-05	0.000431	CcSEcCtD
Cevimeline—Paraesthesia—Orlistat—obesity	9.82e-05	0.000429	CcSEcCtD
Cevimeline—Convulsion—Bupropion—obesity	9.8e-05	0.000428	CcSEcCtD
Cevimeline—Hypertension—Bupropion—obesity	9.76e-05	0.000427	CcSEcCtD
Cevimeline—Dysuria—Topiramate—obesity	9.67e-05	0.000423	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Sibutramine—obesity	9.65e-05	0.000422	CcSEcCtD
Cevimeline—Dyspepsia—Orlistat—obesity	9.63e-05	0.000421	CcSEcCtD
Cevimeline—Chest pain—Bupropion—obesity	9.63e-05	0.000421	CcSEcCtD
Cevimeline—Myalgia—Bupropion—obesity	9.63e-05	0.000421	CcSEcCtD
Cevimeline—Arthralgia—Bupropion—obesity	9.63e-05	0.000421	CcSEcCtD
Cevimeline—Upper respiratory tract infection—Topiramate—obesity	9.61e-05	0.00042	CcSEcCtD
Cevimeline—Anxiety—Bupropion—obesity	9.6e-05	0.000419	CcSEcCtD
Cevimeline—Insomnia—Sibutramine—obesity	9.58e-05	0.000419	CcSEcCtD
Cevimeline—Pollakiuria—Topiramate—obesity	9.55e-05	0.000418	CcSEcCtD
Cevimeline—Erectile dysfunction—Topiramate—obesity	9.52e-05	0.000416	CcSEcCtD
Cevimeline—Discomfort—Bupropion—obesity	9.51e-05	0.000416	CcSEcCtD
Cevimeline—Decreased appetite—Orlistat—obesity	9.51e-05	0.000416	CcSEcCtD
Cevimeline—Paraesthesia—Sibutramine—obesity	9.51e-05	0.000416	CcSEcCtD
Cevimeline—Dyspnoea—Sibutramine—obesity	9.44e-05	0.000413	CcSEcCtD
Cevimeline—Photosensitivity reaction—Topiramate—obesity	9.44e-05	0.000413	CcSEcCtD
Cevimeline—Fatigue—Orlistat—obesity	9.43e-05	0.000412	CcSEcCtD
Cevimeline—Somnolence—Sibutramine—obesity	9.41e-05	0.000411	CcSEcCtD
Cevimeline—Weight increased—Topiramate—obesity	9.41e-05	0.000411	CcSEcCtD
Cevimeline—Weight decreased—Topiramate—obesity	9.36e-05	0.000409	CcSEcCtD
Cevimeline—Pain—Orlistat—obesity	9.36e-05	0.000409	CcSEcCtD
Cevimeline—Hyperglycaemia—Topiramate—obesity	9.33e-05	0.000408	CcSEcCtD
Cevimeline—Dyspepsia—Sibutramine—obesity	9.32e-05	0.000407	CcSEcCtD
Cevimeline—Confusional state—Bupropion—obesity	9.31e-05	0.000407	CcSEcCtD
Cevimeline—Pneumonia—Topiramate—obesity	9.27e-05	0.000405	CcSEcCtD
Cevimeline—Oedema—Bupropion—obesity	9.23e-05	0.000403	CcSEcCtD
Cevimeline—Decreased appetite—Sibutramine—obesity	9.2e-05	0.000402	CcSEcCtD
Cevimeline—Depression—Topiramate—obesity	9.19e-05	0.000402	CcSEcCtD
Cevimeline—Infection—Bupropion—obesity	9.17e-05	0.000401	CcSEcCtD
Cevimeline—Shock—Bupropion—obesity	9.08e-05	0.000397	CcSEcCtD
Cevimeline—Pain—Sibutramine—obesity	9.05e-05	0.000396	CcSEcCtD
Cevimeline—Constipation—Sibutramine—obesity	9.05e-05	0.000396	CcSEcCtD
Cevimeline—Nervous system disorder—Bupropion—obesity	9.05e-05	0.000396	CcSEcCtD
Cevimeline—Neuropathy peripheral—Topiramate—obesity	9.04e-05	0.000395	CcSEcCtD
Cevimeline—Thrombocytopenia—Bupropion—obesity	9.04e-05	0.000395	CcSEcCtD
Cevimeline—Feeling abnormal—Orlistat—obesity	9.02e-05	0.000394	CcSEcCtD
Cevimeline—Tachycardia—Bupropion—obesity	9.01e-05	0.000394	CcSEcCtD
Cevimeline—Stomatitis—Topiramate—obesity	8.99e-05	0.000393	CcSEcCtD
Cevimeline—Skin disorder—Bupropion—obesity	8.97e-05	0.000392	CcSEcCtD
Cevimeline—Urinary tract infection—Topiramate—obesity	8.96e-05	0.000392	CcSEcCtD
Cevimeline—Conjunctivitis—Topiramate—obesity	8.96e-05	0.000392	CcSEcCtD
Cevimeline—Gastrointestinal pain—Orlistat—obesity	8.95e-05	0.000391	CcSEcCtD
Cevimeline—Hyperhidrosis—Bupropion—obesity	8.92e-05	0.00039	CcSEcCtD
Cevimeline—Anorexia—Bupropion—obesity	8.8e-05	0.000385	CcSEcCtD
Cevimeline—Haematuria—Topiramate—obesity	8.79e-05	0.000384	CcSEcCtD
Cevimeline—Feeling abnormal—Sibutramine—obesity	8.73e-05	0.000381	CcSEcCtD
Cevimeline—Epistaxis—Topiramate—obesity	8.7e-05	0.00038	CcSEcCtD
Cevimeline—Urticaria—Orlistat—obesity	8.69e-05	0.00038	CcSEcCtD
Cevimeline—Gastrointestinal pain—Sibutramine—obesity	8.66e-05	0.000378	CcSEcCtD
Cevimeline—Sinusitis—Topiramate—obesity	8.65e-05	0.000378	CcSEcCtD
Cevimeline—Abdominal pain—Orlistat—obesity	8.65e-05	0.000378	CcSEcCtD
Cevimeline—Body temperature increased—Orlistat—obesity	8.65e-05	0.000378	CcSEcCtD
Cevimeline—Hypotension—Bupropion—obesity	8.63e-05	0.000377	CcSEcCtD
Cevimeline—Agranulocytosis—Topiramate—obesity	8.6e-05	0.000376	CcSEcCtD
Cevimeline—Urticaria—Sibutramine—obesity	8.41e-05	0.000368	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Bupropion—obesity	8.41e-05	0.000368	CcSEcCtD
Cevimeline—Abdominal pain—Sibutramine—obesity	8.37e-05	0.000366	CcSEcCtD
Cevimeline—Body temperature increased—Sibutramine—obesity	8.37e-05	0.000366	CcSEcCtD
Cevimeline—Insomnia—Bupropion—obesity	8.35e-05	0.000365	CcSEcCtD
Cevimeline—Haemoglobin—Topiramate—obesity	8.32e-05	0.000364	CcSEcCtD
Cevimeline—Rhinitis—Topiramate—obesity	8.3e-05	0.000363	CcSEcCtD
Cevimeline—Paraesthesia—Bupropion—obesity	8.29e-05	0.000362	CcSEcCtD
Cevimeline—Haemorrhage—Topiramate—obesity	8.28e-05	0.000362	CcSEcCtD
Cevimeline—Hallucination—Topiramate—obesity	8.24e-05	0.00036	CcSEcCtD
Cevimeline—Hypoaesthesia—Topiramate—obesity	8.24e-05	0.00036	CcSEcCtD
Cevimeline—Dyspnoea—Bupropion—obesity	8.23e-05	0.00036	CcSEcCtD
Cevimeline—Pharyngitis—Topiramate—obesity	8.22e-05	0.000359	CcSEcCtD
Cevimeline—Somnolence—Bupropion—obesity	8.21e-05	0.000359	CcSEcCtD
Cevimeline—Oedema peripheral—Topiramate—obesity	8.15e-05	0.000356	CcSEcCtD
Cevimeline—Dyspepsia—Bupropion—obesity	8.13e-05	0.000355	CcSEcCtD
Cevimeline—Urethral disorder—Topiramate—obesity	8.11e-05	0.000355	CcSEcCtD
Cevimeline—Hypersensitivity—Orlistat—obesity	8.06e-05	0.000352	CcSEcCtD
Cevimeline—Decreased appetite—Bupropion—obesity	8.02e-05	0.000351	CcSEcCtD
Cevimeline—Visual impairment—Topiramate—obesity	7.98e-05	0.000349	CcSEcCtD
Cevimeline—Fatigue—Bupropion—obesity	7.96e-05	0.000348	CcSEcCtD
Cevimeline—Constipation—Bupropion—obesity	7.89e-05	0.000345	CcSEcCtD
Cevimeline—Pain—Bupropion—obesity	7.89e-05	0.000345	CcSEcCtD
Cevimeline—Asthenia—Orlistat—obesity	7.85e-05	0.000343	CcSEcCtD
Cevimeline—Hypersensitivity—Sibutramine—obesity	7.8e-05	0.000341	CcSEcCtD
Cevimeline—Pruritus—Orlistat—obesity	7.74e-05	0.000338	CcSEcCtD
Cevimeline—Eye disorder—Topiramate—obesity	7.74e-05	0.000338	CcSEcCtD
Cevimeline—Tinnitus—Topiramate—obesity	7.72e-05	0.000337	CcSEcCtD
Cevimeline—Cardiac disorder—Topiramate—obesity	7.68e-05	0.000336	CcSEcCtD
Cevimeline—Flushing—Topiramate—obesity	7.68e-05	0.000336	CcSEcCtD
Cevimeline—Feeling abnormal—Bupropion—obesity	7.61e-05	0.000332	CcSEcCtD
Cevimeline—Asthenia—Sibutramine—obesity	7.6e-05	0.000332	CcSEcCtD
Cevimeline—Gastrointestinal pain—Bupropion—obesity	7.55e-05	0.00033	CcSEcCtD
Cevimeline—Angiopathy—Topiramate—obesity	7.51e-05	0.000328	CcSEcCtD
Cevimeline—Pruritus—Sibutramine—obesity	7.49e-05	0.000327	CcSEcCtD
Cevimeline—Diarrhoea—Orlistat—obesity	7.49e-05	0.000327	CcSEcCtD
Cevimeline—Chills—Topiramate—obesity	7.43e-05	0.000325	CcSEcCtD
Cevimeline—Urticaria—Bupropion—obesity	7.33e-05	0.000321	CcSEcCtD
Cevimeline—Alopecia—Topiramate—obesity	7.31e-05	0.00032	CcSEcCtD
Cevimeline—Abdominal pain—Bupropion—obesity	7.3e-05	0.000319	CcSEcCtD
Cevimeline—Body temperature increased—Bupropion—obesity	7.3e-05	0.000319	CcSEcCtD
Cevimeline—Diarrhoea—Sibutramine—obesity	7.24e-05	0.000317	CcSEcCtD
Cevimeline—Dizziness—Orlistat—obesity	7.23e-05	0.000316	CcSEcCtD
Cevimeline—Malnutrition—Topiramate—obesity	7.21e-05	0.000315	CcSEcCtD
Cevimeline—Flatulence—Topiramate—obesity	7.1e-05	0.00031	CcSEcCtD
Cevimeline—Dysgeusia—Topiramate—obesity	7.06e-05	0.000308	CcSEcCtD
Cevimeline—Dizziness—Sibutramine—obesity	7e-05	0.000306	CcSEcCtD
Cevimeline—Back pain—Topiramate—obesity	6.97e-05	0.000305	CcSEcCtD
Cevimeline—Vomiting—Orlistat—obesity	6.96e-05	0.000304	CcSEcCtD
Cevimeline—Muscle spasms—Topiramate—obesity	6.93e-05	0.000303	CcSEcCtD
Cevimeline—Rash—Orlistat—obesity	6.9e-05	0.000302	CcSEcCtD
Cevimeline—Dermatitis—Orlistat—obesity	6.89e-05	0.000301	CcSEcCtD
Cevimeline—Headache—Orlistat—obesity	6.85e-05	0.0003	CcSEcCtD
Cevimeline—Hypersensitivity—Bupropion—obesity	6.8e-05	0.000297	CcSEcCtD
Cevimeline—Tremor—Topiramate—obesity	6.75e-05	0.000295	CcSEcCtD
Cevimeline—Vomiting—Sibutramine—obesity	6.73e-05	0.000294	CcSEcCtD
Cevimeline—Ill-defined disorder—Topiramate—obesity	6.69e-05	0.000292	CcSEcCtD
Cevimeline—Rash—Sibutramine—obesity	6.68e-05	0.000292	CcSEcCtD
Cevimeline—Dermatitis—Sibutramine—obesity	6.67e-05	0.000292	CcSEcCtD
Cevimeline—Anaemia—Topiramate—obesity	6.66e-05	0.000291	CcSEcCtD
Cevimeline—Headache—Sibutramine—obesity	6.63e-05	0.00029	CcSEcCtD
Cevimeline—Asthenia—Bupropion—obesity	6.62e-05	0.000289	CcSEcCtD
Cevimeline—Agitation—Topiramate—obesity	6.62e-05	0.000289	CcSEcCtD
Cevimeline—Pruritus—Bupropion—obesity	6.53e-05	0.000285	CcSEcCtD
Cevimeline—Nausea—Orlistat—obesity	6.5e-05	0.000284	CcSEcCtD
Cevimeline—Malaise—Topiramate—obesity	6.5e-05	0.000284	CcSEcCtD
Cevimeline—Vertigo—Topiramate—obesity	6.47e-05	0.000283	CcSEcCtD
Cevimeline—Syncope—Topiramate—obesity	6.46e-05	0.000282	CcSEcCtD
Cevimeline—Leukopenia—Topiramate—obesity	6.45e-05	0.000282	CcSEcCtD
Cevimeline—Palpitations—Topiramate—obesity	6.37e-05	0.000278	CcSEcCtD
Cevimeline—Loss of consciousness—Topiramate—obesity	6.33e-05	0.000277	CcSEcCtD
Cevimeline—Diarrhoea—Bupropion—obesity	6.32e-05	0.000276	CcSEcCtD
Cevimeline—Nausea—Sibutramine—obesity	6.29e-05	0.000275	CcSEcCtD
Cevimeline—Cough—Topiramate—obesity	6.29e-05	0.000275	CcSEcCtD
Cevimeline—Convulsion—Topiramate—obesity	6.24e-05	0.000273	CcSEcCtD
Cevimeline—Hypertension—Topiramate—obesity	6.22e-05	0.000272	CcSEcCtD
Cevimeline—Arthralgia—Topiramate—obesity	6.13e-05	0.000268	CcSEcCtD
Cevimeline—Chest pain—Topiramate—obesity	6.13e-05	0.000268	CcSEcCtD
Cevimeline—Myalgia—Topiramate—obesity	6.13e-05	0.000268	CcSEcCtD
Cevimeline—Anxiety—Topiramate—obesity	6.11e-05	0.000267	CcSEcCtD
Cevimeline—Dizziness—Bupropion—obesity	6.1e-05	0.000267	CcSEcCtD
Cevimeline—Discomfort—Topiramate—obesity	6.06e-05	0.000265	CcSEcCtD
Cevimeline—Confusional state—Topiramate—obesity	5.93e-05	0.000259	CcSEcCtD
Cevimeline—Oedema—Topiramate—obesity	5.88e-05	0.000257	CcSEcCtD
Cevimeline—Vomiting—Bupropion—obesity	5.87e-05	0.000257	CcSEcCtD
Cevimeline—Infection—Topiramate—obesity	5.84e-05	0.000255	CcSEcCtD
Cevimeline—Rash—Bupropion—obesity	5.82e-05	0.000254	CcSEcCtD
Cevimeline—Dermatitis—Bupropion—obesity	5.81e-05	0.000254	CcSEcCtD
Cevimeline—Shock—Topiramate—obesity	5.79e-05	0.000253	CcSEcCtD
Cevimeline—Headache—Bupropion—obesity	5.78e-05	0.000253	CcSEcCtD
Cevimeline—Nervous system disorder—Topiramate—obesity	5.77e-05	0.000252	CcSEcCtD
Cevimeline—Thrombocytopenia—Topiramate—obesity	5.76e-05	0.000252	CcSEcCtD
Cevimeline—Tachycardia—Topiramate—obesity	5.74e-05	0.000251	CcSEcCtD
Cevimeline—Skin disorder—Topiramate—obesity	5.71e-05	0.00025	CcSEcCtD
Cevimeline—Hyperhidrosis—Topiramate—obesity	5.69e-05	0.000249	CcSEcCtD
Cevimeline—Anorexia—Topiramate—obesity	5.61e-05	0.000245	CcSEcCtD
Cevimeline—Hypotension—Topiramate—obesity	5.5e-05	0.00024	CcSEcCtD
Cevimeline—Nausea—Bupropion—obesity	5.48e-05	0.00024	CcSEcCtD
Cevimeline—Musculoskeletal discomfort—Topiramate—obesity	5.36e-05	0.000234	CcSEcCtD
Cevimeline—Insomnia—Topiramate—obesity	5.32e-05	0.000232	CcSEcCtD
Cevimeline—Paraesthesia—Topiramate—obesity	5.28e-05	0.000231	CcSEcCtD
Cevimeline—Dyspnoea—Topiramate—obesity	5.24e-05	0.000229	CcSEcCtD
Cevimeline—Somnolence—Topiramate—obesity	5.23e-05	0.000229	CcSEcCtD
Cevimeline—Dyspepsia—Topiramate—obesity	5.18e-05	0.000226	CcSEcCtD
Cevimeline—Decreased appetite—Topiramate—obesity	5.11e-05	0.000223	CcSEcCtD
Cevimeline—Fatigue—Topiramate—obesity	5.07e-05	0.000222	CcSEcCtD
Cevimeline—Constipation—Topiramate—obesity	5.03e-05	0.00022	CcSEcCtD
Cevimeline—Pain—Topiramate—obesity	5.03e-05	0.00022	CcSEcCtD
Cevimeline—Feeling abnormal—Topiramate—obesity	4.85e-05	0.000212	CcSEcCtD
Cevimeline—Gastrointestinal pain—Topiramate—obesity	4.81e-05	0.00021	CcSEcCtD
Cevimeline—Urticaria—Topiramate—obesity	4.67e-05	0.000204	CcSEcCtD
Cevimeline—Abdominal pain—Topiramate—obesity	4.65e-05	0.000203	CcSEcCtD
Cevimeline—Body temperature increased—Topiramate—obesity	4.65e-05	0.000203	CcSEcCtD
Cevimeline—Hypersensitivity—Topiramate—obesity	4.33e-05	0.000189	CcSEcCtD
Cevimeline—Asthenia—Topiramate—obesity	4.22e-05	0.000184	CcSEcCtD
Cevimeline—Pruritus—Topiramate—obesity	4.16e-05	0.000182	CcSEcCtD
Cevimeline—Diarrhoea—Topiramate—obesity	4.02e-05	0.000176	CcSEcCtD
Cevimeline—Dizziness—Topiramate—obesity	3.89e-05	0.00017	CcSEcCtD
Cevimeline—Vomiting—Topiramate—obesity	3.74e-05	0.000163	CcSEcCtD
Cevimeline—Rash—Topiramate—obesity	3.71e-05	0.000162	CcSEcCtD
Cevimeline—Dermatitis—Topiramate—obesity	3.7e-05	0.000162	CcSEcCtD
Cevimeline—Headache—Topiramate—obesity	3.68e-05	0.000161	CcSEcCtD
Cevimeline—Nausea—Topiramate—obesity	3.49e-05	0.000153	CcSEcCtD
Cevimeline—CYP3A4—Metabolism—ECHS1—obesity	8.27e-06	9.09e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—UCP3—obesity	8.27e-06	9.09e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—UCP2—obesity	8.27e-06	9.09e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HSD11B1—obesity	8.27e-06	9.09e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CETP—obesity	8.24e-06	9.06e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CD—obesity	8.23e-06	9.05e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CD—obesity	8.21e-06	9.02e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SOCS3—obesity	8.21e-06	9.02e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SOCS3—obesity	8.18e-06	8.99e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SDC1—obesity	8.15e-06	8.96e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ADH1B—obesity	8.14e-06	8.94e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GNB3—obesity	8.03e-06	8.83e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKR1C3—obesity	8.02e-06	8.82e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ACSL1—obesity	8.01e-06	8.81e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GPAM—obesity	8.01e-06	8.81e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARGC1B—obesity	8.01e-06	8.81e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GNB3—obesity	8.01e-06	8.8e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—TYK2—obesity	7.92e-06	8.71e-05	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CB—obesity	7.9e-06	8.69e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—TYK2—obesity	7.9e-06	8.68e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SCARB1—obesity	7.89e-06	8.68e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF2—obesity	7.89e-06	8.68e-05	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CB—obesity	7.88e-06	8.66e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF2—obesity	7.87e-06	8.65e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—RHOA—obesity	7.86e-06	8.64e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—MTHFR—obesity	7.85e-06	8.63e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—RHOA—obesity	7.83e-06	8.61e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—GNAS—obesity	7.82e-06	8.6e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—GNAS—obesity	7.8e-06	8.57e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3R1—obesity	7.78e-06	8.55e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PCK1—obesity	7.78e-06	8.55e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HADH—obesity	7.78e-06	8.55e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—FADS1—obesity	7.78e-06	8.55e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3R1—obesity	7.75e-06	8.52e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARA—obesity	7.7e-06	8.47e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SREBF1—obesity	7.66e-06	8.43e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOB—obesity	7.66e-06	8.42e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOB—obesity	7.64e-06	8.4e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ACP5—obesity	7.56e-06	8.32e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL5—obesity	7.48e-06	8.22e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AGT—obesity	7.46e-06	8.2e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL5—obesity	7.46e-06	8.2e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GOT2—obesity	7.45e-06	8.2e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—G6PD—obesity	7.37e-06	8.1e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LPL—obesity	7.31e-06	8.04e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOE—obesity	7.31e-06	8.04e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—FASN—obesity	7.3e-06	8.02e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LPL—obesity	7.29e-06	8.02e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HK1—obesity	7.28e-06	8e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SREBF2—obesity	7.28e-06	8e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—BCHE—obesity	7.26e-06	7.99e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—FOXO1—obesity	7.26e-06	7.98e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RPS6KB1—obesity	7.25e-06	7.97e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—CAV1—obesity	7.24e-06	7.96e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—FOXO1—obesity	7.24e-06	7.96e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RPS6KB1—obesity	7.23e-06	7.94e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—APOA1—obesity	7.23e-06	7.94e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CB—obesity	7.18e-06	7.89e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CB—obesity	7.15e-06	7.87e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPA—obesity	7.03e-06	7.73e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP2E1—obesity	7.01e-06	7.71e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NQO1—obesity	6.93e-06	7.62e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPIN1—obesity	6.88e-06	7.57e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA5—obesity	6.74e-06	7.41e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCD—obesity	6.74e-06	7.41e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCD—obesity	6.72e-06	7.39e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GCG—obesity	6.64e-06	7.3e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—SLC2A4—obesity	6.64e-06	7.3e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CG—obesity	6.6e-06	7.25e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—HTR2A—obesity	6.6e-06	7.25e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—C3—obesity	6.59e-06	7.24e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—HTR2A—obesity	6.57e-06	7.23e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—C3—obesity	6.57e-06	7.22e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYCS—obesity	6.56e-06	7.21e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GGT1—obesity	6.44e-06	7.07e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GOT1—obesity	6.44e-06	7.07e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC22A1—obesity	6.43e-06	7.07e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CLOCK—obesity	6.43e-06	7.07e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PPARG—obesity	6.37e-06	7e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NCOA1—obesity	6.34e-06	6.97e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—POMC—obesity	6.28e-06	6.9e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SULT2A1—obesity	6.27e-06	6.89e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GLP1R—obesity	6.27e-06	6.89e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IRS2—obesity	6.27e-06	6.89e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AGT—obesity	6.26e-06	6.88e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—STK11—obesity	6.25e-06	6.87e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CYP19A1—obesity	6.25e-06	6.87e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IRS2—obesity	6.25e-06	6.87e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—INS—obesity	6.24e-06	6.86e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AGT—obesity	6.24e-06	6.86e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—DPYD—obesity	6.17e-06	6.78e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—LEP—obesity	6.13e-06	6.74e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOE—obesity	6.13e-06	6.74e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOE—obesity	6.11e-06	6.72e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—LEP—obesity	6.11e-06	6.72e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CAV1—obesity	6.07e-06	6.68e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—APOA1—obesity	6.06e-06	6.66e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CAV1—obesity	6.06e-06	6.66e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—APOA1—obesity	6.04e-06	6.64e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PRKAR2B—obesity	5.94e-06	6.53e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—DCN—obesity	5.89e-06	6.48e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—ESR1—obesity	5.85e-06	6.44e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—ESR1—obesity	5.84e-06	6.42e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—COMT—obesity	5.81e-06	6.39e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CD—obesity	5.8e-06	6.38e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—F2—obesity	5.78e-06	6.36e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PRKCB—obesity	5.78e-06	6.36e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PRKCB—obesity	5.76e-06	6.34e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—F2—obesity	5.76e-06	6.34e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CPT1A—obesity	5.73e-06	6.3e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GNB3—obesity	5.73e-06	6.3e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARGC1A—obesity	5.73e-06	6.3e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—ALB—obesity	5.72e-06	6.29e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—BAD—obesity	5.71e-06	6.28e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—HMOX1—obesity	5.7e-06	6.27e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—BAD—obesity	5.7e-06	6.26e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NAMPT—obesity	5.62e-06	6.18e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LIPC—obesity	5.59e-06	6.14e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GCK—obesity	5.59e-06	6.14e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GNAS—obesity	5.58e-06	6.13e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOC3—obesity	5.55e-06	6.1e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CG—obesity	5.53e-06	6.08e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CG—obesity	5.52e-06	6.06e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—NOS3—obesity	5.48e-06	6.02e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3R1—obesity	5.48e-06	6.02e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IRS1—obesity	5.47e-06	6.01e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOB—obesity	5.46e-06	6e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IRS1—obesity	5.45e-06	5.99e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CETP—obesity	5.39e-06	5.93e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SDC1—obesity	5.33e-06	5.86e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—POMC—obesity	5.27e-06	5.79e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—POMC—obesity	5.25e-06	5.77e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKR1C3—obesity	5.24e-06	5.76e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—INS—obesity	5.24e-06	5.76e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—INS—obesity	5.22e-06	5.74e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—LPL—obesity	5.21e-06	5.73e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SCARB1—obesity	5.16e-06	5.67e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—CCL2—obesity	5.15e-06	5.67e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—CCL2—obesity	5.14e-06	5.65e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—GPX1—obesity	5.09e-06	5.59e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IGF1—obesity	5.07e-06	5.57e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT2—obesity	5.06e-06	5.57e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CB—obesity	5.05e-06	5.56e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IGF1—obesity	5.05e-06	5.55e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT2—obesity	5.05e-06	5.55e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SREBF1—obesity	5.01e-06	5.51e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PTGS2—obesity	5.01e-06	5.51e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CD36—obesity	4.95e-06	5.45e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GOT2—obesity	4.87e-06	5.36e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CD—obesity	4.86e-06	5.35e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CD—obesity	4.85e-06	5.33e-05	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—PIK3CA—obesity	4.82e-06	5.3e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—SERPINE1—obesity	4.81e-06	5.29e-05	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—PIK3CA—obesity	4.8e-06	5.28e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—SERPINE1—obesity	4.8e-06	5.27e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—FASN—obesity	4.77e-06	5.24e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—BCHE—obesity	4.75e-06	5.22e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—MTHFR—obesity	4.69e-06	5.16e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TYK2—obesity	4.68e-06	5.14e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TYK2—obesity	4.66e-06	5.13e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—RHOA—obesity	4.64e-06	5.1e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—RHOA—obesity	4.63e-06	5.09e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARA—obesity	4.61e-06	5.06e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3R1—obesity	4.59e-06	5.05e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—NOS3—obesity	4.59e-06	5.05e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP2E1—obesity	4.58e-06	5.04e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3R1—obesity	4.58e-06	5.03e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—NOS3—obesity	4.58e-06	5.03e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NQO1—obesity	4.53e-06	4.98e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AGT—obesity	4.46e-06	4.9e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—PIK3CA—obesity	4.38e-06	4.81e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOE—obesity	4.37e-06	4.8e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—PIK3CA—obesity	4.36e-06	4.8e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GCG—obesity	4.34e-06	4.78e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—SLC2A4—obesity	4.34e-06	4.78e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—CAV1—obesity	4.33e-06	4.76e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—APOA1—obesity	4.32e-06	4.75e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYCS—obesity	4.29e-06	4.71e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MTOR—obesity	4.24e-06	4.66e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CB—obesity	4.24e-06	4.66e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MTOR—obesity	4.23e-06	4.65e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CB—obesity	4.23e-06	4.65e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GGT1—obesity	4.21e-06	4.63e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GOT1—obesity	4.21e-06	4.63e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NCOA1—obesity	4.14e-06	4.56e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—STK11—obesity	4.08e-06	4.49e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CYP19A1—obesity	4.08e-06	4.49e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CG—obesity	3.94e-06	4.34e-05	CbGpPWpGaD
Cevimeline—CHRM1—GPCR downstream signaling—AKT1—obesity	3.94e-06	4.33e-05	CbGpPWpGaD
Cevimeline—CHRM3—GPCR downstream signaling—AKT1—obesity	3.92e-06	4.31e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—IL6—obesity	3.87e-06	4.26e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—IL6—obesity	3.86e-06	4.25e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PPARG—obesity	3.81e-06	4.19e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—COMT—obesity	3.8e-06	4.17e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—POMC—obesity	3.75e-06	4.13e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GNB3—obesity	3.74e-06	4.12e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARGC1A—obesity	3.74e-06	4.12e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—INS—obesity	3.73e-06	4.1e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—HMOX1—obesity	3.73e-06	4.1e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MMP9—obesity	3.69e-06	4.05e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MMP9—obesity	3.67e-06	4.04e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GNAS—obesity	3.65e-06	4.01e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MAPK8—obesity	3.58e-06	3.94e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling by GPCR—AKT1—obesity	3.57e-06	3.93e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MAPK8—obesity	3.57e-06	3.93e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOB—obesity	3.57e-06	3.92e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling by GPCR—AKT1—obesity	3.56e-06	3.92e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CD—obesity	3.47e-06	3.81e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—ALB—obesity	3.42e-06	3.76e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—LPL—obesity	3.41e-06	3.75e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—GPX1—obesity	3.33e-06	3.66e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—STAT3—obesity	3.28e-06	3.6e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3R1—obesity	3.27e-06	3.6e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—NOS3—obesity	3.27e-06	3.6e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—STAT3—obesity	3.27e-06	3.59e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CD36—obesity	3.24e-06	3.56e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—PIK3CA—obesity	3.08e-06	3.39e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—MTHFR—obesity	3.07e-06	3.37e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—MYC—obesity	3.04e-06	3.35e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—TGFB1—obesity	3.04e-06	3.34e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—MYC—obesity	3.04e-06	3.34e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—TGFB1—obesity	3.03e-06	3.33e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CB—obesity	3.02e-06	3.32e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARA—obesity	3.01e-06	3.31e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PTGS2—obesity	2.99e-06	3.29e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AGT—obesity	2.92e-06	3.21e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOE—obesity	2.86e-06	3.14e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—CAV1—obesity	2.83e-06	3.11e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—APOA1—obesity	2.82e-06	3.11e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—PIK3CA—obesity	2.58e-06	2.84e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CG—obesity	2.58e-06	2.84e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—PIK3CA—obesity	2.58e-06	2.83e-05	CbGpPWpGaD
Cevimeline—CHRM3—Metabolism—AKT1—obesity	2.52e-06	2.77e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PPARG—obesity	2.49e-06	2.74e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—POMC—obesity	2.45e-06	2.7e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—INS—obesity	2.44e-06	2.68e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—IL6—obesity	2.29e-06	2.52e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—IL6—obesity	2.28e-06	2.51e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CD—obesity	2.27e-06	2.49e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—ALB—obesity	2.24e-06	2.46e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3R1—obesity	2.14e-06	2.35e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—NOS3—obesity	2.14e-06	2.35e-05	CbGpPWpGaD
Cevimeline—CHRM1—Signaling Pathways—AKT1—obesity	2.11e-06	2.32e-05	CbGpPWpGaD
Cevimeline—CHRM3—Signaling Pathways—AKT1—obesity	2.1e-06	2.31e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CB—obesity	1.98e-06	2.17e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PTGS2—obesity	1.96e-06	2.15e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—PIK3CA—obesity	1.84e-06	2.03e-05	CbGpPWpGaD
Cevimeline—CYP2D6—Metabolism—AKT1—obesity	1.51e-06	1.65e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—PIK3CA—obesity	1.2e-06	1.32e-05	CbGpPWpGaD
Cevimeline—CYP3A4—Metabolism—AKT1—obesity	9.84e-07	1.08e-05	CbGpPWpGaD
